Amneal Pharmaceuticals Inc. (NASDAQ: AMRX) announced it will acquire 100% of Kashiv BioSciences, LLC in a transaction valued at $750 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE